|Other Accession||Q5EAA5, Q5R7E2|
|Other Names||T-cell leukemia translocation-altered gene protein, T-cell leukemia translocation-associated gene protein, TCTA|
|Target/Specificity||The synthetic peptide sequence is selected from aa 23-35 of HUMAN TCTA|
|Format||Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Function||May be required for cellular fusion during osteoclastogenesis.|
|Cellular Location||Membrane; Multi-pass membrane protein|
|Tissue Location||Ubiquitous. Highest level of expression in kidney. Present in monocytes, osteoclasts, macrophages, synoviocytes and synovial lining cells (at protein level)|
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
May be required for cellular fusion during osteoclastogenesis.
Aplan P.D.,et al.Cancer Res. 55:1917-1921(1995).
Ota T.,et al.Nat. Genet. 36:40-45(2004).
Ebert L.,et al.Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
Muzny D.M.,et al.Nature 440:1194-1198(2006).
Kotake S.,et al.Bone 45:627-639(2009).
If you have any additional inquiries please email technical services at email@example.com.